IMMT transfers technology to convert bauxite waste into refractory bricks, enabling cost-effective production and addressing industrial and environmental challenges ...

QINGDAO, SHANDONG, CHINA, January 28, 2026 /EINPresswire.com/ — In the context of rapid global infrastructure and industrial manufacturing development, the demand ...

AI models are designing new metal alloys that have been 3D-printed and tested in the lab. The results are then fed back into the AI to accelerate alloy discovery.

In late 2025, SELLAS Life Sciences Group reported encouraging Phase 2 data for SLS009 in combination with azacitidine and venetoclax in relapsed or refractory acute myeloid leukemia and confirmed that ...

The bispecific T-cell engager talquetamab (Talvey) has some distinct adverse events (AEs) compared with drugs of the same class that target B-cell maturation antigen (BCMA) in mul ...

Bristol Myers Squibb (NYSE:BMY) received U.S. FDA approval for Sotyktu (deucravacitinib) as the first TYK2 inhibitor for adults with active psoriatic arthritis. The company reported positive interim ...

A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...

As nonprofit-governed Servier continues to make gains with its IDH-mutant glioma med Voranigo, the drugmaker is wading deeper into the rare oncology arena with a new M&A play.  | Servier on Friday ...

Q4 2025 Earnings Call March 2, 2026 3:30 AM ESTCompany ParticipantsStefan Borgas - CEO & Executive DirectorIan Botha - ...

From hypersonic aircraft to nuclear-powered submarines , many of today's most advanced defense systems rely on a special class of materials known ...

Cohort 19 brings eight deep‑tech startups to ISU’s Startup Factory, showcasing breakthroughs from sustainable concrete to space‑ready hardware.